ByrneJA, CarpenterJE, CarterC, et al.Building research support capacity across human health biobanks during the COVID-19 pandemic. Biomarker Insights, 2021; 16:1–9.
2.
Simeon-DubachD, HendersonMK. Sustainability in biobanking. Biopreserv Biobank, 2014; 12:287–291.
3.
ChalmersD, NicolD, KayeJ, et al.Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era. BMC Med Ethics, 2016; 17:39.
4.
DoucetM, YuilleM, GeorghiouL, et al.Biobank sustainability: Current status and future prospects. J Biorepos Sci App Med, 2017; 5:1–7.
5.
RushA, CatchpooleDR, LingR, et al.Improving academic biobank value and sustainability through an outputs focus. Value Health, 2020; 23:1072–1078.
6.
StephensN, DimondR. Closure of a human tissue biobank: Individual, institutional, and field expectations during cycles of promise and disappointment. New Genet Soc, 2015; 34:417–436.
7.
AardenE. Projecting and producing ‘usefulness' of biomedical research infrastructures; or why the Singapore Tissue Network closed. Sci Public Policy, 2017; 44:753–762.
8.
LarssonA, SavageC, BrommelsM, et al.Structuring a research infrastructure: A study of the rise and fall of a large-scale distributed biobank facility. Soc Sci Info, 2018; 57:196–222.
